Drupal.behaviors.print = function(context) {window.print();window.close();}>

Rosetta Licenses Canadian Rights to miRNA Diagnostics to Warnex

August 13, 2009

Rosetta Licenses Canadian Rights to miRNA Diagnostics to Warnex

Warnex will market the tests and send tissue samples from its customers to Rosetta's Philadelphia-based lab for analysis.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories